PT-129
PT-129 is a PROTAC degrader targeting the G3BP1/2 NTF2 domain to disrupt stress granule assembly and disassemble existing granules. This action inhibits ATF4-mediated signaling between fibroblasts and cancer cells, providing a tool for studying cancer cell stress resilience and tumor-stroma communication in vitro and in vivo.
Product Specifications
Field of Research
Cell Biology, Molecular Biology, Pharmacology & Drug Discovery
Smiles
O=C (N (C1C (NC (CC1) =O) =O) C2=O) C3=C2C=CC=C3NCCOCCOCCOCCC (NC4=CC=C (NC ([C@H] (CC5=CC=CC=C5) NS (=O) (CC (N6C (C=CC=C7) =C7C=N6) =O) =O) =O) C=C4) =O
Molecular Formula
C46H48N8O12S
Molecular Weight
936.98
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![6 (R) -[2- (8 (S) - (2,2-Dimethyl-d6-butyryl) oxy]-2 (S),6 (R) -dimethyl-1,2,6,7,8,8a (R) -hexahydro-1 (S) -naphthyl]ethyl-4 (R) - (t-butyl-dimethylsilyl) oxy-3,4,5,6-tetrahydro-2H-pyran-2-one](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
D3548 5 mg
6 (R) -[2- (8 (S) - (2,2-Dimethyl-d6-butyryl) oxy]-2 (S),6 (R) -dimethyl-1,2,6,7,8,8a (R) -hexahydro-1 (S) -naphthyl]ethyl-4 (R) - (t-butyl-dimethylsilyl) oxy-3,4,5,6-tetrahydro-2H-pyran-2-one
Sign In for Pricing
View Details 